博士論文

Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH

Persistent ID (NDL)
info:ndljp/pid/11115463
Material type
博士論文
Author
柴, 久美子
Publisher
柴, 久美子
Publication date
2018
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
東京医科歯科大学,博士(医学)
View All

Notes on use at the National Diet Library

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
柴, 久美子
Publication, Distribution, etc.
Publication Date
2018
Publication Date (W3CDTF)
2018
Alternative Title
SGLT2阻害薬カナグリフロジンはNASHモデルマウスの肝臓癌の発生を抑制する
Degree grantor/type
東京医科歯科大学
Date Granted
2018-03-22
Date Granted (W3CDTF)
2018-03-22